NASDAQ · Biotechnology

PEPG (PEPG) Stock

$1.76 -3.83% NASDAQ: PEPG Healthcare

Valuation

MetricValue
Price$1.76
Market Cap$121.74M
P/E Ratio-0.68
P/B Ratio0.68
P/S Ratio0.00
EPS (TTM)$-2.12
52-Week High$7.80
52-Week Low$1.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-61.22%
ROA-51.72%
ROCE-63.51%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.12
Current Ratio11.62

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-27.0M$-68.0M$-85.0M$-98.0M$-94.0M
Net Profit$-27.0M$-69.0M$-79.0M$-90.0M$-90.0M
EPS$-1.22$-4.42$-3.30$-2.85$-2.12
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$144.0M$217.0M$143.0M$151.0M$174.0M
Total Liabilities$11.0M$38.0M$35.0M$32.0M$26.0M
Cash$133.0M$182.0M$81.0M$49.0M$61.0M
Borrowings$0$25.0M$20.0M$19.0M$17.0M

Latest News

Craig-Hallum Initiates PepGen at Buy With $11 Price Target MT Newswires · Jun 16, 2026 PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner Zacks · May 20, 2026 PepGen Files $400 Million Mixed Shelf MT Newswires · May 19, 2026 Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now? Insider Monkey · May 18, 2026 PepGen (PEPG) Upgraded to Buy: Here's What You Should Know Zacks · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-59.0M$-69.0M$-82.0M$-82.0M
Investing Cash Flow$-1.0M$-8.0M$-35.0M$-38.0M$-15.0M
Financing Cash Flow$-1.0M$-2.0M$0$2.0M$0
Net Cash Flow$125.0M$49.0M$-101.0M$-31.0M$11.0M
Free Cash Flow$-23.0M$-63.0M$-72.0M$-83.0M$-82.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-77.58%
Quick Ratio14.98
Interest Coverage—
Return 1Y89.15%
Return 3Y-69.73%
Return 5Y—

Ownership

Insiders Held0.23%
Institutions Held88.37%
Institutions Float Held88.58%
Institutional HolderSharesReport Date
RA Capital Management, L.P.20,064,5452026-03-31
Commodore Capital Lp4,475,0002026-03-31
Viking Global Investors, L.P.3,482,4342026-03-31
Laurion Capital Management, LP2,750,8552026-03-31
Vivo Capital, LLC2,325,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About PEPG

PEPG is led by CEO James G. McArthur, employs 79 people, headquartered in US, publicly traded since 2022.

PEPG stock trades at $1.76 with a market capitalization of $121.74M. The stock is valued at a price-to-earnings (P/E) ratio of -0.68, price-to-book of 0.68, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.01 and $7.80, and currently trades 77.4% below its 52-week high.

On profitability, PEPG generates a return on equity (ROE) of -61.22%, return on capital employed of -63.51%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides